Looking for an LED TV? We've got you covered.
3D TV is here in plenty of time for the World Cup 3D TV is here
Zep'lin concept design by Damien Grossemy Zep'lin flying boat ponders the future of electric vehicles
Bertone designed Alfa Romeo Pandion Cylon on wheels - the Bertone designed Alfa Romeo Pandion
Apple's iKey would see your keys and wallet replaced by an iPhone or similar device Apple to replace keys and wallet with iKey app?
The Martin Aircraft jetpack is the first commercially-available jetpack It's 2010 - finally my jet pack is here!
MORE TOP STORIES »
HEALTH AND WELLBEING

Potential new drug delivery system

By Sandra Arcaro

21:17 August 31, 2009

Co-authors Tambet Teesalu and Kazuki N. Sugahara proudly display their laboratory-develope...

Co-authors Tambet Teesalu and Kazuki N. Sugahara proudly display their laboratory-developed drug-delivery system

Image Gallery (2 images)

Scientists at UC Santa Barbara have developed a biological mechanism that can act as an entirely new means of drug delivery, carrying with it the potential to make treating illness even more effective. Rather than simply circulating in the bloodstream, the laboratory-developed peptide can deliver nanoparticles directly into tissue.

Senior author Erkki Ruoslahti of the Burnham Institute for Medical Research at UCSB explains, “when giving a drug to a patient, it circulates in the bloodstream, but often doesn’t get into the tissue. This is especially true with tumors.”

Ruoslahti’s team conducted a study using prostate cancer cells to determine whether the peptide, essentially a small piece of protein they developed, could successfully transport “cargo” to the targeted cancer tissue. Like a passenger on a bus arriving at its destination, the cargo - in this case drug nanoparticles or even other cells - exits the blood vessel and then goes about its business, which is to penetrate the target tissue.

How the peptide understands where and when to dislodge its cargo is embedded in its design. The peptide has a built-in exit, known as a “C terminal” which contains the “motif”—an amino acid sequence that causes tissue penetration. Like a door, the “C terminal” must be open for the drug to penetrate the tissue. The peptide’s success in delivering its cargo hinges on this fact. So reliant is this delivery system on the “C terminal” that the team have coined it the “C-end rule,” or CendR, pronounced “sender.”

As important a component as the CendR is, it is not without flaw. It ushers in life-saving drugs to treat sick tissue, but it also acts as a gateway for potentially life-threatening viruses to hijack cells. According to Ruoslahti, the CendR is “a natural system. We’re not quite clear what its exact function is, but viruses appear to take advantage of it.”

Exactly how viruses use this system requires further research so that inhibitors can be developed to prevent viruses from entering the cell. The results of this study are published in Proceedings of the National Academy of Sciences.

Post a Comment

Login with your gizmag account:




Or Login with Facebook:


Connect

Related Articles Email this article to a friend

Just enter your friends and your email address into the form below ...




Privacy is safe with us because we have a strict privacy policy.

Recent popular articles in Health and Wellbeing
Recent Comments